News Agency
The Times

Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal

  • Written by PR Newswire
Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal

Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical trials in Alzheimer's disease and major depressive disorder 

SYDNEY, Feb. 12, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the publication of its most recent peer-reviewed journal article entitled Clinical Pharmacology...

Read more: Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat)...

Manage Workplace Challenges Through an Employment Lawyer in Melbourne

Managing employees and maintaining a compliant workplace involves navigating a range of legal responsibilities. From employment agreements and workplace policies to disputes and employee management matters, businesses need to understand their obligations to protect both their organisation and their employees.  At... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion